Purchase Order 75F40124P00204
Award Date 6/24/24
Potential Completion Date 12/31/24
Potential Value $121K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Germany
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
4
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Food and Drug Administration (FDA) awarded a $48,680.00 firm fixed price purchase order to Emulate Inc., a for-profit small business, for the purchase of Emulate Chip-S1 Basic Research Kits. This contract supports the FDA's regulatory science initiatives and advances the agency's work on non-animal testing approaches. The award has an ultimate completion date of August 21, 2025. Emulate Inc. has previously received federal grants, including a cooperative agreement from the Defense Advanced...
- This is a $79,500 firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian agency, to Nortis Inc., a for-profit manufacturer of biotechnology products and services. The contract is for the provision of a Parvivo System, which is an organ-on-a-chip technology. The contract has no set-aside designation and was awarded in September 2020, with a completion date of September 2021. Nortis Inc. has received prior federal grant awards from agencies such as...
- The Food and Drug Administration awarded a $31,950 purchase order to Emulate Inc. on June 18, 2025, for twelve Chip-R1 Rigid Chip basic research kits under a total small business set-aside designation. The contract, which extends to October 16, 2025, represents a firm fixed price procurement of the company's organ-on-chip technology. Emulate Inc., headquartered in Boston, Massachusetts, specializes in microphysiological systems that replicate human organ functions to support advanced...
- The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a $111,539.32 firm-fixed-price purchase order to EHT Technologies GMBH, a for-profit limited liability company manufacturer, for a Test System of Engineered Heart Tissues (EHT). This system will be used by the FDA's Division of Applied Regulatory Science to study variations in heart cell contractility resulting from exposure to certain drugs or drug combinations in a more mature setting. The contract...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order contract to Emulate Inc., doing business as Emulate, a for-profit organization. The $200,300.00 contract is for the provision of a human emulation system, which is a set-aside for small businesses. Emulate's organ-on-a-chip technology is designed to model human biology for biomedical research, supporting federal initiatives in areas like personalized medicine, biosurveillance,...
- This is a firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Mattek Corporation, a for-profit manufacturer of human tissue models. The $20,802 contract is for the delivery of reconstructed human pigmented epidermis samples and maintenance media, to be completed by November 20, 2024. The contract has no set-aside designation. Mattek has a history of providing human tissue models to federal agencies like the National Institutes of Health (NIH), Centers for Disease...
- The U.S. Food and Drug Administration (FDA) awarded a $42,455 firm-fixed-price purchase order to Fluigent, Inc., a foreign-owned for-profit organization, for the procurement of microfluidic equipment for organ-on-a-chip studies. This contract, awarded on July 13, 2024, has a completion date of July 14, 2025 and was not set aside for any specific business category. Fluigent, Inc. is a specialized provider of microfluidic solutions, including automated perfusion systems, pressure generators, and...
- The Department of Health and Human Services Food and Drug Administration awarded a $149,130 firm fixed price purchase order to Emulate Inc., doing business as Emulate, for the delivery of a CDER-2023-117371-ZOE MODULE (ZOE-CM2) WITH AN ORB HUB (ORB-HM1) MCMI23 - ROBUST ORGAN-ON-A-CHIP SYSTEM FOR BIOASSAY DEVELOPMENT. This award responds to Solicitation 75F40123Q00376 which sought a robust organ-on-a-chip system to support the FDA's bioassay development work. Place of performance will be...
- The Food and Drug Administration's National Center for Toxicological Research awarded a $39,857 firm fixed-price purchase order to Mattek Corporation, a small business specializing in advanced human tissue models. The contract, designated as a total small business set-aside and awarded on June 23, 2025, requires delivery of reconstructed human microtissue samples and associated culture media by December 31, 2025. Specifically, Mattek will supply 144 reconstructed human small intestine tissue...
- Emulate Inc., a Boston-based biotechnology company specializing in organ-on-chip technology, was awarded a $145,260 firm fixed-price purchase order by the Food and Drug Administration on August 1, 2024. The contract calls for delivery of the CHIP-S1 Stretchable Chip (catalog number 10231-2) with an ultimate completion date of August 31, 2024. This award was designated as a Total Small Business set-aside, recognizing Emulate's status as a small business entity. The Food and Drug Administration, a...